New combo procedure may stop deadly bleeding in rare vein disorder
NCT ID NCT07310316
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at a two-part procedure to prevent repeat bleeding in people with cavernous transformation of the portal vein, a rare condition where the main vein to the liver is blocked. The procedure involves blocking the bleeding veins and partially blocking the splenic artery to reduce pressure. Researchers will track 26 patients to see if this approach lowers the chance of rebleeding compared to standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Variceal embolization combined with partial splenic artery embolization
- What this could lead to
- If successful, this combined procedure could offer a new way to control bleeding in patients with this rare vein condition who don't respond to standard treatments.
- What could go wrong
- This is a small, early retrospective study with only 26 participants, so results may not apply broadly. The procedure carries risks like bleeding, infection, or worsening liver function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAVERNOUS TRANSFORMATION OF PORTAL VEIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Air Force Military Medical University
RECRUITINGXi'an, Shaanxi, 710032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.